ProPhase Labs, Inc. (PRPH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.30 per share a year ago. These figures ...

GARDEN CITY, NY, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the closing of its ...

ProPhase Labs PRPH is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at ...

On Friday, ProPhase Labs Inc (PRPH) stock saw a decline, ending the day at $0.78 which represents a decrease of $-0.65 or -45.45% from the prior close of $1.43. The stock opened at $0.7 and touched a ...

ProPhase Labs (PRPH) announced that it intends to offer to sell shares of its common stock in an underwritten public offering. All of the ...

Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 GARDEN CITY, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs ...

英为财情Investing.com - ProPhase Labs (NASDAQ: PRPH )星期三发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益低于分析师的预期。 在该公司发布的最新财报中，公司每股收益为$-0.350，总营收为$3.15M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$2.82M，每股收益为$-0.310.

ProPhase Labs, Inc. is a medical science and technology company, which engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter consumer healthcare ...

Theravance Biopharma (TBPH) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.01 per share a year ago. These figures ...

在充满挑战的市场环境中，ProPhase Labs, Inc. (PRPH)的股价触及52周新低，达到1.99美元。这一最新跌幅凸显了该公司正经历的艰难时期，过去一年其股价已下跌55.27%。投资者一直密切关注ProPhase Labs，因为它正在应对一系列显著影响其市场估值的不利因素。52周新低作为公司业绩和投资者情绪的关键指标，标志着该股票在过去一年中的最低交易价格。随着ProPhase ...

ThinkEquity is acting as sole book-running manager for the offering.